Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma

  • Terashima T
  • Morizane C
  • Hiraoka N
 et al. 
  • 12


    Mendeley users who have this article in their library.
  • 23


    Citations of this article.


The chemotherapy for small-cell lung carcinoma (SCLC) has been adopted for advanced extrapulmonary neuroendocrine carcinomas (EP-NECs). The aim of this study was to clarify the efficacy of standard SCLC regimens when used to treat EP-NECs and to compare the outcome with that for SCLC.

Author-supplied keywords

  • Chemotherapy
  • Extrapulmonary neuroendocrine carcinoma
  • Prognosis
  • Prognostic factor
  • Small-cell lung carcinoma

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free